These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1087 related items for PubMed ID: 7954462

  • 1. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF, Sutton VR, Li W, Burgess J, McKEnzie IF, Pietersz GA, Trapani JA.
    Cancer Res; 1994 Dec 01; 54(23):6160-6. PubMed ID: 7954462
    [Abstract] [Full Text] [Related]

  • 2. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N.
    Cancer Res; 1994 Mar 15; 54(6):1511-6. PubMed ID: 8137257
    [Abstract] [Full Text] [Related]

  • 3. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2.
    Sutton VR, Burgess J, Pietersz GA, Li WJ, McKenzie IF, Trapani JA.
    Ther Immunol; 1994 Apr 15; 1(2):83-93. PubMed ID: 7584487
    [Abstract] [Full Text] [Related]

  • 4. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T, Kuroki M, Arakawa F, Yamamoto T, Kuwahara M, Haruno M, Ikeda S, Matsuoka Y.
    Anticancer Res; 1998 Apr 15; 18(1A):17-24. PubMed ID: 9568050
    [Abstract] [Full Text] [Related]

  • 5. Tumor-specific IgE-mediated inhibition of human colorectal carcinoma xenograft growth.
    Kershaw MH, Darcy PK, Trapani JA, MacGregor D, Smyth MJ.
    Oncol Res; 1998 Apr 15; 10(3):133-42. PubMed ID: 9700724
    [Abstract] [Full Text] [Related]

  • 6. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK, Horton L, Flahart RE, O'Rear L, Crumpacker D, Imbaratto JW, Yannelli JR, Robinson RR, Oldham RK.
    Hum Antibodies Hybridomas; 1990 Apr 15; 1(2):66-76. PubMed ID: 2103354
    [Abstract] [Full Text] [Related]

  • 7. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N, Leprieur S, Clémenceau B, Supiot S, Sébille-Rivain V, Faivre-Chauvet A, Davodeau F, Paris F, Barbet J, Aubry J, Birklé S.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
    Shaw DR, Khazaeli MB, Sun LK, Ghrayeb J, Daddona PE, McKinney S, LoBuglio AF.
    J Immunol; 1987 Jun 15; 138(12):4534-8. PubMed ID: 3584980
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR, Mezzanzanica D, Sanborn D, Casalini P, Colnaghi MI, Zurawski VR.
    Cancer Res; 1994 May 01; 54(9):2448-55. PubMed ID: 7512887
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H, Arakawa F, Imakiire T, Kuroki M, Kuroki M.
    Anticancer Res; 2003 May 01; 23(6a):4383-8. PubMed ID: 14666725
    [Abstract] [Full Text] [Related]

  • 16. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
    Neumaier M, Shively L, Chen FS, Gaida FJ, Ilgen C, Paxton RJ, Shively JE, Riggs AD.
    Cancer Res; 1990 Apr 01; 50(7):2128-34. PubMed ID: 2107969
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
    Gillies SD, Lan Y, Lo KM, Super M, Wesolowski J.
    Cancer Res; 1999 May 01; 59(9):2159-66. PubMed ID: 10232603
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.
    Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM.
    Cancer Res; 1992 Oct 15; 52(20):5713-9. PubMed ID: 1394194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.